Amphastar Pharmaceuticals, Inc.·4

Dec 12, 8:37 PM ET

Shohet Stephen B. 4

4 · Amphastar Pharmaceuticals, Inc. · Filed Dec 12, 2018

Insider Transaction Report

Form 4
Period: 2018-12-10
Transactions
  • Exercise/Conversion

    Common Stock

    2018-12-10$14.66/sh+58,557$858,44689,263 total
  • Sale

    Common Stock

    2018-12-10$21.72/sh58,557$1,271,78230,706 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2018-12-1058,5570 total
    Exercise: $14.66Exp: 2018-12-20Common Stock (58,557 underlying)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.125 to $22.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  • [F2]Shares subject to the option are fully vested and immediately exercisable.

Documents

1 file
  • 4
    a4.xmlPrimary

    4